|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to PRWeb Archives
PRWeb: 12-10-2004
Hundreds of affected consumers are now bringing cases against Merck, the maker of Vioxx. [PRWEB Dec 10, 2004]
RIC International has appointed Dr. Xaiojun (June) Xie as the company's new Director of Medical Translation. [PRWEB Dec 10, 2004]
Medical consultations and prescription drugs like Xanax, Valium, and Ativan are available at Web-Doctor-Online-Pharmacy.com. [PRWEB Dec 9, 2004]
Studies show that for people with pancreatic cancer and men with prostate cancer, PC Hope is associated with significant improvements in quality of life, reductions in patients’ pain rating, and a decline in PSA levels for prostate cancer patients—all without major side effects. [PRWEB Dec 9, 2004]
LogiXML, Inc., a leading provider of web-based business intelligence reporting and analysis tools, and Sierra Scientific Software, Inc. (Sierra) today announced their strategic partnership to add LogiXML’s LGX Info functionality to Sierra’s Clinical Research Information System (CRIS) version 8. [PRWEB Dec 9, 2004]
Texas Children’s Hospital is the first recipient of Baxa Corporation’s award for Best Practices in the pharmacy. Texas Children’s Hospital was honored with the 2004 Best Practices Award at a Baxa customer appreciation reception held December 7, 2004, at the 30th Annual American Society of Health-System Pharmacists Mid-Year Clinical Meeting in Orlando, Florida. Pharmacy Manager, Lai Lao accepted the award on behalf of the hospital. [PRWEB Dec 9, 2004]
Peter Rost of Pfizer and Eshetu Wondemagegnehu of the World Health Organization speak out about the re-importation of drugs into the USA and strategies for combating counterfeit drugs at Xtalks web conference. [PRWEB Dec 9, 2004]
Research and Markets (researchandmarkets.com/reports/c10683) has announced the addition of The World Market for OTC Healthcare to their offering. [PRWEB Dec 9, 2004]
Wireless tagging technology could help health providers save lives, improve workflow efficiency and reduce the cost of caring for patients. However, according to a report to be published later this week by the Cambridge UK based consultancy Wireless Healthcare, a fear of job losses and the belief that the provision of healthcare cannot be automated will slow the deployment of potentially life saving technology. [PRWEB Dec 8, 2004]
The United States Patent and Trademark Office has issued an Order granting the Public Patent Foundation's Request for Reexamination of Pfizer's patent on Lipitor, touted by the pharmaceutical giant as being "the best-selling treatment for lowering cholesterol and the best-selling pharmaceutical product of any kind in the world." In its Order, the Patent Office found that PUBPAT's request raised "a substantial new question of patentability" regarding all 44 claims of the patent. [PRWEB Dec 8, 2004]
Research and Markets (researchandmarkets.com/reports/c10451) has announced the addition of Commercial Insight: Antihypertensives - Can Manufacturers Maintain Value? to their offering. [PRWEB Dec 8, 2004]
[PRWEB Dec 8, 2004]
[PRWEB Dec 8, 2004]
As the FDA deals with pharmaceutical complications, alternative health medicines gain attention. [PRWEB Dec 7, 2004]
Canolio, recently launched Sexy Ganja a lubricating gel created using the HomeoSativa process and combining homeopathic techniques with the use of hemp oil. Sexy Ganja offers all the therapeutic benefits of hemp along with the numerous advantages of using a lubricating gel. [PRWEB Dec 7, 2004]
Prescription weight loss pills and prescription diet pills online at US-Meds.com. [PRWEB Dec 6, 2004]
MAb therapies brought in revenues of over $5.1 billion in 2003 and will continue to grow at an impressive rate throughout the next five years. Revenues should nearly triple during this time as a result of the launch of a plethora of new MAbs and the approval of new indications for MAbs already on the market. By 2008, MAbs should account for 32 percent of all revenue in the biotech market. [PRWEB Dec 6, 2004]
Research and Markets (researchandmarkets.com/reports/c10472) has announced the addition of Curative Health Services Inc. - Pharmatrack to their offering. [PRWEB Dec 6, 2004]
Research and Markets (researchandmarkets.com/reports/c10621) has announced the addition of A Guide to Good Manufacturing Practice, 2nd Edition to their offering. [PRWEB Dec 6, 2004]
Dublin--Research and Markets (http://www.researchandmarkets.com/reports/c10654) has announced the addition of Structure-Guided Drug Design: Rediscovering the Importance of Drug Structure for Drug Discovery to their offering [PRWEB Dec 6, 2004]
Research and Markets (researchandmarkets.com/reports/c10585) has announced the addition of Inkine Pharmaceutical Company Inc. - PharmaTrack to their offering. [PRWEB Dec 5, 2004]
Research and Markets (researchandmarkets.com/reports/c10628) has announced the addition of Savient Pharmaceuticals Inc. - PharmaTrack to their offering. [PRWEB Dec 5, 2004]
Thermogenesis weight loss has a specific dynamic action on food that combine energetic spending and the rise metabolism which result on burning the existing fat (natural fat burner) and the fat we will absorb during the day. [PRWEB Dec 4, 2004]
Research and Markets (researchandmarkets.com/reports/c10475) has announced the addition of Cytogen Corporation - PharmaTrack to their offering. [PRWEB Dec 4, 2004]
Research and Markets (researchandmarkets.com/reports/c10480) has announced the addition of Hi-Tech Pharmacal Co. Inc. - PharmaTrack to their offering [PRWEB Dec 4, 2004]
Research and Markets (http://www.researchandmarkets.com/reports/c10565) has announced the addition of ICON Plc. - PharmaTrack to their offering [PRWEB Dec 4, 2004]
The nomination of François Arcand as Director General (CEO) of ERA Plantech S.L., effective immediately, was announced during BioSpain by Dr. Luis Ruiz-Avila, on behalf of the board of directors. [PRWEB Dec 3, 2004]
Many overweight individuals search for the weight loss product which best works for them. How does Xenical differ from Phentermine, Meridia and other appetite suppressant drugs? [PRWEB Dec 3, 2004]
Baxa Corporation is sponsoring a presentation to discuss the new sterile compounding requirements under USP Chapter 797. The Exhibitor’s Theatre presentation, “USP 797: A Practical Approach to Compliance,” will detail the most costly areas of compliance and review the necessary financial and operational resources. The program will take place on Tuesday, December 7th at the meeting of the American Society of Health-System Pharmacists (ASHP) to be held at the Orange County Convention Center in Orlando, Florida. [PRWEB Dec 2, 2004]
The molecular pharming company ERA-Plantech announced today at BioSpain the nomination of Medicago co-founder and current President of the Society for Moleculture, François Arcand as its "Director General" (CEO) [PRWEB Dec 2, 2004]
|
|
